Key findings
Pharma companies are taking steps to address access in low-income countries, but significant gaps remain
19 November 2024
Camille Romero to attend Trilateral Technical Symposium on Strengthening Manufacturing Capacities to Respond to the Non-Communicable Diseases Burden
The Access to Medicine Foundation is co-organising a technical symposium with the World Health Organization (WHO) and the World Intellectual Property Organization (WIPO) at the World Trade Organization (WTO). Camille Romero, the Foundation’s Access to Medicine Research Programme Manager, will attend one of the sessions. In presenting the Foundation’s work, she will highlight key insights from the recently launched 2024 Index, with a focus on local manufacturing and licensing.
Date
13 December 2024
Location
Geneva, Switzerland
The Trilateral Symposium is the eleventh in a series of joint technical symposia on public health, intellectual property, and trade organized by WHO, WIPO, and the WTO. It builds on the agencies' collaborative efforts to strengthen Members’ capacity to address issues at the intersection of health, trade, and intellectual property. This year’s event, co-organised by the Foundation, focuses on the burden of non-communicable diseases (NCDs) and the promotion of innovation and access to health technologies for NCDs.
As a representative of the Foundation, Camille will participate in the second session of the event, titled “Coordinating Action through Local and Regional Manufacturing Capacity: Key Stakeholders, Challenges, and Opportunities.” Drawing on key findings from the newly released 2024 Access to Medicine Index, she will discuss how companies are focusing on NCDs. Additionally, Camille will spotlight the progress made by pharmaceutical companies in local manufacturing and licensing of essential medicines, while also addressing areas that require improvement, particularly in underserved countries.
